Investigating how lymphatics affect muscle health in Duchenne muscular dystrophy
Official title: Role of Skeletal Muscle Lymphatics in Duchenne Muscular Dystrophy Regulation
Funded at Texas A&m University Health Science Ctr · NIH-11067785 · Data updated 2026-11-12
This study is looking at how improving the lymphatic system might help reduce inflammation and boost muscle health in people with Duchenne muscular dystrophy (DMD), with hopes of finding new treatments to make life better for those affected by this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project start | May 24, 2022 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $445,162 |
| NIH project number | 5R01AR080129-04 |
| Project ID | NIH-11067785 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Duchenne muscular dystrophy, particularly those experiencing significant muscle weakness and inflammation.
✕Less likely to help
Patients with other forms of muscular dystrophy or those without significant muscle inflammation may not benefit from this research.
What this research studies
This research focuses on understanding the role of lymphatic vessels in Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease. The study aims to explore how enhancing lymphatic function can reduce inflammation and improve muscle health in affected individuals. By examining animal models, researchers will investigate the mechanisms behind lymphangiogenesis and its potential to promote muscle healing. The ultimate goal is to develop new therapeutic strategies that could lead to better outcomes for patients with DMD.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that improve muscle function and reduce inflammation in patients with Duchenne muscular dystrophy.
How similar studies have gone: Previous research has shown promising results in using lymphatic modulation to improve muscle health, indicating that this approach may be viable for treating DMD.
Where this research is happening
-
Texas A&m University Health Science Ctr
College Station, United States Active
Researchers
- Principal investigator: Muthuchamy, Mariappan — Texas A&m University Health Science Ctr
- Study coordinator: Muthuchamy, Mariappan
Related research
Other NIH-funded projects on the same topics.
-
Advancing manufacturing and release testing for a Duchenne gene editing therapy
A project to optimize how a dual-vector AAV gene editing treatment for Duchenne muscular dystrophy is made and tested, so it can move toward clinical use.
-
Understanding why Duchenne Muscular Dystrophy worsens and how to stop it
A research team at USC is studying Duchenne muscular dystrophy to find out why the disease continues to progress and how to interrupt harmful changes in muscle tissue.
-
Stopping steroid-related muscle and bone wasting in Duchenne muscular dystrophy
Researchers are testing ways to protect muscles and bones in people with Duchenne muscular dystrophy who take long-term steroid medicines.
-
MR clues to how nNOS affects energy use and blood flow in Becker and Duchenne muscular dystrophy
This project looks at how advanced MRI tests can track muscle energy and blood flow changes in people with Becker and Duchenne muscular dystrophy as new gene therapies are explored.
-
Digital motor-skill tracking for infants with Duchenne Muscular Dystrophy using wearables
A wearable-sensor project aims to quietly track and quantify how motor skills develop in babies and young boys with Duchenne Muscular Dystrophy.
-
Genetic factors that influence Duchenne Muscular Dystrophy progression
A study to find genes that change how severe Duchenne muscular dystrophy is in boys and young men, using patient data and DNA samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.